39 results
6-K
EX-3.1
LSB
LakeShore Biopharma Co., Ltd
27 Sep 24
LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation
7:15am
of such dividend may be forfeited by the Board of Directors and, if so forfeited, shall revert to the Company.
ACCOUNTS, AUDIT AND ANNUAL RETURN
6-K/A
EX-99.2
LSB
LakeShore Biopharma Co., Ltd
10 Sep 24
Current report (foreign) (amended)
4:00pm
of such dividend may be forfeited by the Board of Directors and, if so forfeited, shall revert to the Company.
ACCOUNTS, AUDIT AND ANNUAL RETURN
6-K
lpfq74c2mv6g bnyirdv
10 Jun 24
Report of Foreign Private Issuer
7:01am
6-K
EX-99.3
zd0sqjanhkj1udvrpt2p
7 May 24
Report of Foreign Private Issuer
4:30pm
6-K
EX-99.1
s6m7lpu5sqi3 tjqmfk
5 Mar 24
YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries
8:06am
6-K
EX-99.4
s93jfxc8yqhshnqk3yaz
14 Feb 24
Report of Foreign Private Issuer
8:05am
POS AM
6eperz15 d1dcxvd542
23 Jan 24
Prospectus update (post-effective amendment)
4:18pm
6-K
EX-99.1
mpdnnvle9
8 Jan 24
YS Biopharma Announces Changes to its Board Committees
7:10am
6-K
wnjraymsd2jwd 5d6hx
12 Dec 23
Report of Foreign Private Issuer
6:37am
424B3
8xhtij4u
15 Aug 23
Prospectus supplement
8:00am
POS AM
4wy0x7 nviwvffiuils
8 Aug 23
Prospectus update (post-effective amendment)
4:06pm
20-F
EX-12.1
38vhe4feeq8iuj
26 Jul 23
Annual report (foreign)
4:02pm
20-F
xaq9iw93i8u5kz9r scm
26 Jul 23
Annual report (foreign)
4:02pm
20-F
EX-12.2
je3s6y
26 Jul 23
Annual report (foreign)
4:02pm